#686,605 OF 915,843 IN HEALTHCARE
⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
AI Visibility Scorecard
Endobal endocannabinoid system targeted for the Treatment of ALS
endobal.com · Healthcare
Borderline visible. AI bots can crawl Endobal endocannabinoid system targeted for the Treatment of ALS, but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.
Monitoring for AI engine activity
In the Engagemii AEO index
#686,605 of 915,843 in Healthcare for AI visibility
4
AEO Visibility
iNear-invisible · 3.9/10
0
Muse Index Score
iAI agent readiness
Not agent-ready · 0/100
0
AI Adoption
iNone detected · 0/100
About Endobal endocannabinoid system targeted for the Treatment of ALS
from our crawl and measurement
"Endobal by Canna Pharms is the World's First Endocannabinoid System Targeted Treatment for ALS. Endobal can Delay Onset, Slow Progression and Prolong Lifespan of patients with Amyotrophic." That is how Endobal endocannabinoid system targeted for the Treatment of ALS introduces itself. When AI engines look at it, they find little to work with. It scores 3.9 out of 10.
Our crawl found a readable heading structure. It is missing structured data describing the business, an llms.txt file and a sitemap.
The 6 signals AI reads
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Weak
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Weak
Experience, Expertise, Authority, Trust markers.
Technical AEO
Fair
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Strong
Sitemaps and entity links AI can follow.
Off-page authority
How the web signals your brand to AI
Backlinks
Weak
No inbound links found yet.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 3.9/10, Endobal endocannabinoid system targeted for the Treatment of ALS is crawlable but under-signaled - fixable, and the signals above are where to start.
Frequently Asked Questions
How Does ENDOBAL™ Work?
ENDOBAL™ is a groundbreaking product that operates by specifically targeting the endocannabinoid system. Through its interaction with the CB1 and CB2 receptors, it effectively reduces neuroinflammation and oxidative stress by modulating glutamate production and intake. This unique mechanism of action provides neuroprotection to motor neurons and promotes neurogenesis in brain regions critical for motor function.
ENDOBAL™ Side Effects?
When taken as a standalone treatment, ENDOBAL™ has not been linked to any major long-term side effects, offering a reassuring safety profile. However, it is critically important to understand that ENDOBAL™ can interact with other medications you may be taking. These interactions have the potential to significantly alter the effectiveness of your current prescriptions.
Is this your brand?
The exact fixes for Endobal endocannabinoid system targeted for the Treatment of ALS
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Endobal endocannabinoid system targeted for the Treatment of ALS.
Source & Attribution
Scored by Engagemii on September 25, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/endobal
Cite this score: Engagemii (2026). "AEO Score for Endobal endocannabinoid system targeted for the Treatment of ALS." Retrieved from https://engagemii.com/aeo/brands/endobal
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform